글로벌 중재 심장학 시장 – 2030년까지의 산업 동향 및 예측

중재 심장학 시장 분석 및 규모

심혈관 질환의 유병률 증가와 기술 발전으로 인해 중재적 심장학 시장의 설계와 기능이 크게 개선되었으며 시장 성장의 길이 열렸습니다. 또한, 증가하는 의료비 지출과 노령 인구 증가가 시장 성장에 기여합니다.

Data Bridge Market Research는 2022년에 146억 1천만 달러였던 글로벌 중재 심장학 시장이 2030년까지 236억 1천만 달러로 급증할 것으로 분석했으며, 예측 기간 동안 7.1%의 CAGR을 기록할 것으로 예상합니다. 이는 다양한 용도로 중재 심장학이 발전하게 된 기술의 발전으로 인해 기존 장치 세그먼트가 시장의 장치 유형 세그먼트를 지배하고 있음을 나타냅니다.

Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

중재 심장학 시장 범위 및 세분화

Market Definition

Interventional cardiology is a branch of cardiology that focuses on diagnosing and treating cardiovascular diseases using minimally invasive techniques. The global interventional cardiology market refers to the worldwide market for medical devices and procedures used in interventional cardiology. Physicians use catheters (thin, flexible tubes) and other medical devices in interventional cardiology to access and treat the heart and blood vessels. These procedures are typically performed through small incisions or punctures in the skin rather than through open surgery, which helps reduce risks, complications, and recovery time for patients.

Global Interventional Cardiology Market Dynamics

Drivers

• Increasing prevalence of cardiovascular diseases

The rising incidence of cardiovascular diseases, such as coronary artery disease, heart attacks, and cardiac arrhythmias, is a major driver for market growth. The need for effective diagnosis and treatment of these conditions has led to the growth in demand for interventional cardiology procedures.

• Preference for minimally invasive procedures

Interventional cardiology procedures are minimally invasive, meaning they involve smaller incisions and have shorter recovery times compared to traditional open-heart surgeries. As patients and physicians increasingly prefer minimally invasive procedures, the demand for interventional cardiology is expected to rise.

• Technological advancements

Advances in interventional cardiology technologies and techniques have greatly improved the outcomes of cardiac procedures. Innovations such as drug-eluting stents, bioresorbable stents, and Transcatheter Aortic Valve Replacement (TAVR) have revolutionized the field, attracting both patients and healthcare providers to interventional cardiology procedures.

Opportunities

• Increasing healthcare expenditure

Increased healthcare spending, particularly in developing countries, has led to improved access to advanced cardiac care, including interventional cardiology. As governments and healthcare organizations invest in upgrading medical infrastructure and facilities, the interventional cardiology market is likely to expand.

• Growing elderly population

The global population is aging, and elderly individuals are more susceptible to cardiovascular diseases. With the increasing aging population, there is a higher demand for interventional cardiology procedures to diagnose and treat cardiac conditions in this group, driving the market growth.

Restraint

• High cost of interventional procedures

Interventional cardiology procedures, such as angioplasty and stenting, can be costly. The high cost can limit access to these procedures in developing countries and create financial burdens for patients and healthcare systems in general.

Challenge

• Stringent regulatory approval processes

The development and commercialization of interventional cardiology devices require extensive clinical trials and regulatory approvals. Stringent regulatory processes can significantly delay the introduction of new devices and technologies to the market, affecting the growth potential of the industry.

This global interventional cardiology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on this market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In May 2023, Abbott announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations
• In May 2022, Babson Diagnostics, a science-first healthcare technology company, and BD, a leading global medical technology company, announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing.

Global Interventional Cardiology Market Scope

The global interventional cardiology market is segmented into two notable segments based on device type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Device Type

• Conventional Device
• Advanced Device

End User

• Hospitals
• Clinics
• Cardiac Catheterization Laboratories
• Ambulatory Surgical Centres
• Others

Global Interventional Cardiology Market Regional Analysis/Insights

The global interventional cardiology market is analysed and market size insights and trends are provided by device type and end user as referenced above.

The countries covered in this market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.

North America dominates the global interventional cardiology market due to the presence of major key players, high disposable income, high healthcare expenditure, and a well-developed healthcare sector in this region.

Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to increasing R&D activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global interventional cardiology market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2015-2020.

Competitive Landscape and Global Interventional Cardiology Market Share Analysis

The global interventional cardiology market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to market .

Some of the major players operating in the global interventional cardiology market  are:

• ABIOMED, Inc. (U.S.)
• ACIST Medical Systems (U.S.)
• B. Braun Melsungen AG (U.S.)
• Biotronik SE & Co. KG (Germany)
• Boston Scientific Corporation (U.S.)
• BD (U.S.)
• Cook (U.S.)
• Cardinal Health (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Ivascular (Spain)
• Johnson & Johnson Services, Inc. (U.S.)
• 메드트로닉(미국)
• 메리트 메디컬 시스템(미국)
• Koninklijke Philips NV(미국)
• 애벗(미국)
• 테루모 주식회사(일본)
• 론티스 코퍼레이션(스위스)
• WL Gore & Associates, Inc. (미국)
• 바이오센서스 인터내셔널 그룹, 유한회사(미국)
• 제너럴 일렉트릭 컴퍼니(미국)

SKU-60994